Yujin Jin
- Pharmacology top 10%
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 2
-
- Ginseng Biological Effects and Applications 9
- Genomics, phytochemicals, and oxidative stress 3
- Glycosylation and Glycoproteins Research 1
-
- Immune Response and Inflammation 3
- Immune Cell Function and Interaction 2
-
- Autophagy in Disease and Therapy 2
- Co-authors
- Kyung‐Sun HeoDiem Thi Ngoc HuynhChang‐Seon MyungKeon Wook KangEunjeong ParkWon-Joong JeongDong‐Woog ChoiJaeyoung Park
- Journals
- Archives of Pharmacal Research (7 papers)Life Sciences (2 papers)Journal of Pharmaceutical Investigation (2 papers)
- Partner nations
- South KoreaVietnam
In The Last Decade
Yujin Jin
21 papers receiving 360 citations
Peers
Comparison fields: 5 of 79
- Pharmacology 57
- Cancer Research 91
- Molecular Biology 242
- Clinical Biochemistry 21
- Immunology 61
Countries citing papers authored by Yujin Jin
This map shows the geographic impact of Yujin Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujin Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujin Jin more than expected).
Fields of papers citing papers by Yujin Jin
This network shows the impact of papers produced by Yujin Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujin Jin. The network helps show where Yujin Jin may publish in the future.
Co-authorship network
The 10 scholars most cited alongside Yujin Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 11 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 10 | |
| 5 | 2022 | 18 | |
| 6 | 2022 | 16 | |
| 7 | 2022 | 27 | |
| 8 | 2022 | 21 | |
| 9 | 2022 | 8 | |
| 10 | 2021 | 43 | |
| 11 | 2021 | 40 | |
| 12 | 2021 | 38 | |
| 13 | 2021 | 35 | |
| 14 | 2020 | 30 | |
| 15 | 2019 | 13 | |
| 16 | 2019 | 14 | |
| 17 | 2019 | 3 | |
| 18 | 2018 | 14 | |
| 19 | 2017 | 12 | |
| 20 | 2016 | 2 |
About Yujin Jin
Yujin Jin is a scholar working on Cancer Research, Immunology, Pharmacology, Molecular Biology and Geology, having authored 21 papers that have together received 363 indexed citations. Recurring topics across this work include Ginseng Biological Effects and Applications (9 papers), Cancer-related molecular mechanisms research (6 papers), Genomics, phytochemicals, and oxidative stress (3 papers), Immune Response and Inflammation (3 papers), Immune Cell Function and Interaction (2 papers), MicroRNA in disease regulation (2 papers), Autophagy in Disease and Therapy (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Pharmacology (57 citations), Cancer Research (91 citations), Molecular Biology (242 citations), Clinical Biochemistry (21 citations) and Immunology (61 citations). Yujin Jin has collaborated with scholars based in South Korea and Vietnam. Frequent co-authors include Kyung‐Sun Heo, Diem Thi Ngoc Huynh, Chang‐Seon Myung, Keon Wook Kang, Eunjeong Park, Won-Joong Jeong, Dong‐Woog Choi, Jaeyoung Park, Jeong‐Sook Park and Dong‐Hyun Kim. Their work appears in journals such as Archives of Pharmacal Research, Life Sciences, Journal of Pharmaceutical Investigation, Cancers and BMB Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.